Publications by authors named "Merrill Egorin"

Claim this Profile
A
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Paula M Fracasso, George A Fisher, Sherry A Goodner, Jan H Beumer, Merrill J Egorin

Am J Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini, Merrill J Egorin

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini, Merrill J Egorin

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia.
Jonathan How, Mark D Minden, Leber Brian, Eric X Chen, Joseph Brandwein, Merrill J Egorin

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma.
Dae-Hee Lee, Ying Zhang, Amin B Kassam, Myung-Jin Park, Paul Gardner, Merrill J Egorin

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612).
Robert A Parise, Julie L Eiseman, Dana M Clausen, Kimberly P Kicielinski, Pamela A Hershberger, Merrill J Egorin

Cancer Chemother Pharmacol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.
Miguel Muzzio, Shu-Chieh Hu, Julianne L Holleran, Robert A Parise, Julie L Eiseman, Merrill J Egorin

Cancer Chemother Pharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).
Jan H Beumer, Kouros Owzar, Lionel D Lewis, Chen Jiang, Julianne L Holleran, Merrill J Egorin

Cancer Chemother Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers.
Hussein A Tawbi, An L Tran, Susan M Christner, Yan Lin, Matthew Johnson, Merrill J Egorin

Cancer Chemother Pharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.
Jianxia Guo, Dana M Clausen, Jan H Beumer, Robert A Parise, Merrill J Egorin

Cancer Chemother Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.
Robert A Parise, Bean N Anyang, Julie L Eiseman, Merrill J Egorin, Joseph M Covey

Cancer Chemother Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).
Lionel D Lewis, Antonius A Miller, Kouros Owzar, Robert R Bies, Svetlana Markova, Merrill J Egorin

Pharmacogenet Genomics· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib.
Karen E Mulder, Merrill J Egorin, Michael B Sawyer

Invest New Drugs· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.
Michael J Pishvaian, Rebecca Slack, Eunice Y Koh, Jan H Beumer, Marion L Hartley, Merrill J Egorin

Cancer Chemother Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
Eric A Sherer, Mark E Sale, Bruce G Pollock, Chandra P Belani, Merrill J Egorin

J Pharmacokinet Pharmacodyn· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors.
Abdulateef O Aregbe, Eric A Sherer, Merrill J Egorin, Howard I Scher, David B Solit

Cancer Chemother Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
Prithviraj Bose, Edward B Perkins, Connie Honeycut, Martha D Wellons, Tammy Stefan, Merrill J Egorin

Cancer Chemother Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will imatinib compromise reproductive capacity?
Alberuni M Zamah, Michael J Mauro, Brian J Druker, Kutluk Oktay, Merrill J Egorin

Oncologist· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.
Gopa Iyer, Michael J Morris, Dana Rathkopf, Susan F Slovin, Macaulay Steers, Merrill J Egorin

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Ticiana B Leal, Scot C Remick, Chris H Takimoto, Ramesh K Ramanathan, Angela Davies, Merrill J Egorin

Cancer Chemother Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Jonathan Hebb, Sarit Assouline, Caroline Rousseau, Pierre Desjardins, Stephen Caplan, Merrill J Egorin

Cancer Chemother Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Anastasios Stathis, Sebastien J Hotte, Eric X Chen, Holger W Hirte, Amit M Oza, Merrill J Egorin

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma.
Katie M Nemeth, Sara Federico, Angel M Carcaboso, Ying Shen, Paula Schaiquevich, Merrill Egorin

Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.
Henry B Koon, Barbara Fingleton, Jeannette Y Lee, Julia T Geyer, Ethel Cesarman, Merrill J Egorin

J Acquir Immune Defic Syndr· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.
Suresh S Ramalingam, Shivaani Kummar, John Sarantopoulos, Stephen Shibata, Patricia LoRusso, Merrill J Egorin

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis